Sinteza（STZ）株式概要Sinteza S.A.はルーマニアで基礎有機化学製品を生産・販売している。 詳細STZ ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6報酬当社が推定した公正価値より84.3%で取引されている リスク分析過去5年間で収益は年間33.6%減少しました。 収益が 100 万ドル未満 ( RON391K )意味のある時価総額がありません ( RON35M )すべてのリスクチェックを見るSTZ Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueRON Current PriceRON 0.53103.0k% 割高 内在価値ディスカウントEst. Revenue$PastFuture-11m43m2016201920222025202620282031Revenue RON 26.9kEarnings RON 2.5kAdvancedSet Fair ValueView all narrativesSinteza S.A. 競合他社S.C. Institutul de Cercetari Pentru Acoperiri Avansate - ICAASymbol: BVB:ICEVMarket cap: RON 3.4mNorofertSymbol: BVB:NRFMarket cap: RON 46.8mS.C. RomcarbonSymbol: BVB:ROCEMarket cap: RON 89.8mS.C. HeliosSymbol: BVB:HEALMarket cap: RON 30.4m価格と性能株価の高値、安値、推移の概要Sinteza過去の株価現在の株価RON 0.5352週高値RON 2.2252週安値RON 0.45ベータ0.291ヶ月の変化-9.00%3ヶ月変化-10.85%1年変化-75.87%3年間の変化46.93%5年間の変化102.31%IPOからの変化1,270.15%最新ニュースNew Risk • May 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (RON391k revenue, or US$88k). Market cap is less than US$10m (RON36.4m market cap, or US$8.19m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change).Reported Earnings • Apr 29Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).お知らせ • Apr 26Sinteza S.A. to Report Fiscal Year 2025 Results on Apr 23, 2026Sinteza S.A. announced that they will report fiscal year 2025 results on Apr 23, 2026Reported Earnings • Mar 02Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).New Risk • Dec 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON460k revenue, or US$105k). Market cap is less than US$10m (RON43.3m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Net income: RON732.7k (up RON2.11m from 3Q 2024).最新情報をもっと見るRecent updatesNew Risk • May 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (RON391k revenue, or US$88k). Market cap is less than US$10m (RON36.4m market cap, or US$8.19m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change).Reported Earnings • Apr 29Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).お知らせ • Apr 26Sinteza S.A. to Report Fiscal Year 2025 Results on Apr 23, 2026Sinteza S.A. announced that they will report fiscal year 2025 results on Apr 23, 2026Reported Earnings • Mar 02Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).New Risk • Dec 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON460k revenue, or US$105k). Market cap is less than US$10m (RON43.3m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Net income: RON732.7k (up RON2.11m from 3Q 2024).New Risk • Oct 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON43.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 31% per year over the past 5 years. Revenue is less than US$1m (RON566k revenue, or US$129k). Market cap is less than US$10m (RON43.6m market cap, or US$9.95m).Reported Earnings • Sep 01Second quarter 2025 earnings releasedSecond quarter 2025 results: Net loss: RON1.89m (loss widened 56% from 2Q 2024).Buy Or Sell Opportunity • Jul 10Now 20% overvaluedOver the last 90 days, the stock has fallen 64% to RON0.79. The fair value is estimated to be RON0.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.New Risk • May 31New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON39.7m (US$8.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 26% per year over the past 5 years. Revenue is less than US$1m (RON680k revenue, or US$153k). Market cap is less than US$10m (RON39.7m market cap, or US$8.90m).Reported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023).New Risk • Mar 13New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: RON2.8m (US$601k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (RON2.8m revenue, or US$601k). Minor Risk Market cap is less than US$100m (RON154.7m market cap, or US$33.7m).Reported Earnings • Mar 05Full year 2024 earnings releasedFull year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023).Reported Earnings • Nov 17Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON631.7k (down 81% from 3Q 2023). Net loss: RON1.38m (loss widened 16% from 3Q 2023).Buy Or Sell Opportunity • Nov 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.2% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Oct 21Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.7% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Oct 04Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to RON0.24. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Sep 16Now 28% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.7% to RON0.23. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Reported Earnings • Sep 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON655.5k (down 86% from 2Q 2023). Net loss: RON1.22m (loss narrowed 43% from 2Q 2023).Reported Earnings • May 19First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON2.19m (down 40% from 1Q 2023). Net loss: RON2.74m (loss widened 67% from 1Q 2023).New Risk • Apr 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Romanian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$10m (RON16.9m market cap, or US$3.70m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-RON2.5m). Revenue is less than US$5m (RON15m revenue, or US$3.2m).Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: RON18.1m (down 53% from FY 2022). Net loss: RON10.7m (loss widened 411% from FY 2022).Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: RON5.04m (down 48% from 2Q 2022). Net loss: RON2.13m (loss widened RON2.11m from 2Q 2022).Board Change • Jun 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: RON3.64m (down 77% from 1Q 2022). Net loss: RON1.64m (down 181% from profit in 1Q 2022).Board Change • Nov 17No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Buying Opportunity • Sep 27Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only.分析記事 • Sep 26A Look At The Intrinsic Value Of S.C. Sinteza S.A. (BVB:STZ)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of S.C. Sinteza S.A...Buying Opportunity • May 04Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 4.6%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Board Change • Apr 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Apr 12Estimating The Fair Value Of S.C. Sinteza S.A. (BVB:STZ)Does the April share price for S.C. Sinteza S.A. ( BVB:STZ ) reflect what it's really worth? Today, we will estimate...Buying Opportunity • Apr 04Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Reported Earnings • Mar 04Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: RON43.3m (up 97% from FY 2020). Net income: RON1.26m (up RON6.48m from FY 2020). Profit margin: 2.9% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates.Reported Earnings • Sep 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: RON10.9m (up 83% from 2Q 2020). Net income: RON780.2k (up RON1.31m from 2Q 2020). Profit margin: 7.1% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue.Board Change • Sep 01No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 29Full year 2020 earnings releasedThe company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: RON22.0m (down 2.3% from FY 2019). Net loss: RON5.23m (loss widened 27% from FY 2019).分析記事 • Jan 05Is S.C. Sinteza (BVB:STZ) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...株主還元STZRO ChemicalsRO 市場7D-3.3%0.5%3.3%1Y-75.9%-12.4%74.1%株主還元を見る業界別リターン: STZ過去 1 年間で-12.4 % の収益を上げたRO Chemicals業界を下回りました。リターン対市場: STZは、過去 1 年間で74.1 % のリターンを上げたRO市場を下回りました。価格変動Is STZ's price volatile compared to industry and market?STZ volatilitySTZ Average Weekly Movement6.6%Chemicals Industry Average Movement5.5%Market Average Movement5.0%10% most volatile stocks in RO Market13.2%10% least volatile stocks in RO Market2.9%安定した株価: STZ 、 RO市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: STZの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト190528Stan Geluwww.sinteza.roSinteza S.A.はルーマニアで基礎有機化学製品を製造・販売している。同社は安息香酸と安息香酸液を提供している。同社の製品は、有機合成の中間体、腐食防止剤、アルキド樹脂、重合プロセス、プラスチック、食品保存料、動物飼料添加物、医薬品、化粧品などに使用されている。同社は製品を直接販売するほか、ヨーロッパとトルコの代理店を通じて販売している。Sinteza S.A.は1905年に設立され、ルーマニアのオラデアに拠点を置く。もっと見るSinteza S.A. 基礎のまとめSinteza の収益と売上を時価総額と比較するとどうか。STZ 基礎統計学時価総額RON 34.78m収益（TTM）-RON 3.38m売上高(TTM)RON 391.42k88.8xP/Sレシオ-10.3xPER（株価収益率STZ は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計STZ 損益計算書（TTM）収益RON 391.42k売上原価RON 1.01m売上総利益-RON 617.46kその他の費用RON 2.76m収益-RON 3.38m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.051グロス・マージン-157.75%純利益率-863.33%有利子負債／自己資本比率0%STZ の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/14 12:42終値2026/05/14 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sinteza S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (RON391k revenue, or US$88k). Market cap is less than US$10m (RON36.4m market cap, or US$8.19m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change).
Reported Earnings • Apr 29Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).
お知らせ • Apr 26Sinteza S.A. to Report Fiscal Year 2025 Results on Apr 23, 2026Sinteza S.A. announced that they will report fiscal year 2025 results on Apr 23, 2026
Reported Earnings • Mar 02Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).
New Risk • Dec 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON460k revenue, or US$105k). Market cap is less than US$10m (RON43.3m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).
Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Net income: RON732.7k (up RON2.11m from 3Q 2024).
New Risk • May 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (RON391k revenue, or US$88k). Market cap is less than US$10m (RON36.4m market cap, or US$8.19m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change).
Reported Earnings • Apr 29Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).
お知らせ • Apr 26Sinteza S.A. to Report Fiscal Year 2025 Results on Apr 23, 2026Sinteza S.A. announced that they will report fiscal year 2025 results on Apr 23, 2026
Reported Earnings • Mar 02Full year 2025 earnings releasedFull year 2025 results: Net loss: RON3.44m (loss narrowed 61% from FY 2024).
New Risk • Dec 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Revenue is less than US$1m (RON460k revenue, or US$105k). Market cap is less than US$10m (RON43.3m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).
Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Net income: RON732.7k (up RON2.11m from 3Q 2024).
New Risk • Oct 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON43.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 31% per year over the past 5 years. Revenue is less than US$1m (RON566k revenue, or US$129k). Market cap is less than US$10m (RON43.6m market cap, or US$9.95m).
Reported Earnings • Sep 01Second quarter 2025 earnings releasedSecond quarter 2025 results: Net loss: RON1.89m (loss widened 56% from 2Q 2024).
Buy Or Sell Opportunity • Jul 10Now 20% overvaluedOver the last 90 days, the stock has fallen 64% to RON0.79. The fair value is estimated to be RON0.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
New Risk • May 31New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON39.7m (US$8.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 26% per year over the past 5 years. Revenue is less than US$1m (RON680k revenue, or US$153k). Market cap is less than US$10m (RON39.7m market cap, or US$8.90m).
Reported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023).
New Risk • Mar 13New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: RON2.8m (US$601k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (RON2.8m revenue, or US$601k). Minor Risk Market cap is less than US$100m (RON154.7m market cap, or US$33.7m).
Reported Earnings • Mar 05Full year 2024 earnings releasedFull year 2024 results: Net loss: RON6.75m (loss narrowed 37% from FY 2023).
Reported Earnings • Nov 17Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON631.7k (down 81% from 3Q 2023). Net loss: RON1.38m (loss widened 16% from 3Q 2023).
Buy Or Sell Opportunity • Nov 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.2% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Oct 21Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.7% to RON0.25. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Oct 04Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to RON0.24. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Sep 16Now 28% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.7% to RON0.23. The fair value is estimated to be RON0.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Reported Earnings • Sep 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON655.5k (down 86% from 2Q 2023). Net loss: RON1.22m (loss narrowed 43% from 2Q 2023).
Reported Earnings • May 19First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON2.19m (down 40% from 1Q 2023). Net loss: RON2.74m (loss widened 67% from 1Q 2023).
New Risk • Apr 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Romanian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$10m (RON16.9m market cap, or US$3.70m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-RON2.5m). Revenue is less than US$5m (RON15m revenue, or US$3.2m).
Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: RON18.1m (down 53% from FY 2022). Net loss: RON10.7m (loss widened 411% from FY 2022).
Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: RON5.04m (down 48% from 2Q 2022). Net loss: RON2.13m (loss widened RON2.11m from 2Q 2022).
Board Change • Jun 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: RON3.64m (down 77% from 1Q 2022). Net loss: RON1.64m (down 181% from profit in 1Q 2022).
Board Change • Nov 17No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Buying Opportunity • Sep 27Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
分析記事 • Sep 26A Look At The Intrinsic Value Of S.C. Sinteza S.A. (BVB:STZ)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of S.C. Sinteza S.A...
Buying Opportunity • May 04Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 4.6%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Board Change • Apr 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Apr 12Estimating The Fair Value Of S.C. Sinteza S.A. (BVB:STZ)Does the April share price for S.C. Sinteza S.A. ( BVB:STZ ) reflect what it's really worth? Today, we will estimate...
Buying Opportunity • Apr 04Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be RON0.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Reported Earnings • Mar 04Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: RON43.3m (up 97% from FY 2020). Net income: RON1.26m (up RON6.48m from FY 2020). Profit margin: 2.9% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates.
Reported Earnings • Sep 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: RON10.9m (up 83% from 2Q 2020). Net income: RON780.2k (up RON1.31m from 2Q 2020). Profit margin: 7.1% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue.
Board Change • Sep 01No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 29Full year 2020 earnings releasedThe company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: RON22.0m (down 2.3% from FY 2019). Net loss: RON5.23m (loss widened 27% from FY 2019).
分析記事 • Jan 05Is S.C. Sinteza (BVB:STZ) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
